NOVOCURE LTD shareholders Q3 2023

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 46,416$749,6180.09%
XTX Topco Ltd 31,991$516,6550.09%
Y-Intercept (Hong Kong) Ltd 50,383$813,6850.08%
FRONTIER CAPITAL MANAGEMENT CO LLC 424,437$6,854,6580.08%
Bayesian Capital Management, LP 39,716$641,4130.07%
Coatue Management 885,675$14,303,6510.07%
Leucadia National 492,790$7,958,5590.07%
C WorldWide Group Holding A/S 221,784$3,5820.05%
FORA Capital, LLC 33,641$543,3020.05%
Linden Thomas Advisory Services, LLC 12,949$209,1260.05%
Teza Capital Management LLC 27,944$451,2960.04%
TWO SIGMA ADVISERS, LP 922,400$14,896,7600.04%
TWO SIGMA INVESTMENTS, LP 846,565$13,672,0250.04%
BALYASNY ASSET MANAGEMENT L.P. 1,109,615$17,920,2820.04%
Capital International Investors 9,004,492$145,427,2670.04%
Connor, Clark & Lunn Investment Management Ltd. 408,839$6,602,7500.04%
OCCUDO QUANTITATIVE STRATEGIES LP 14,511$234,3530.03%
SG Americas Securities, LLC 160,886$2,5980.03%
Capital World Investors 8,878,731$143,393,8630.03%
Trexquant Investment LP 66,565$1,075,0250.03%
External links

This page lists NOVOCURE LTD's shareholders in Q3 2023. To view NOVOCURE LTD's shareholder history, click here.